Novoron Bioscience Awarded NIH Grant for Research Into Alzheimer’s Disease

SAN DIEGO: SAN DIEGO, Jan. 28, 2022 /PRNewswire/ -- Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, announced today that they have been awarded an NIA/NIH grant to advance their work into Alzheimer's Disease (AD), chronic traumatic encephalopathy (CTE), and other...

Click to view original post